Limitations of the International HIV Dementia Scale in the current era
- 13 November 2018
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 32 (17) , 2477-2483
Abstract
The International HIV Dementia Scale (IHDS) was developed as a tool to detect HIV-dementia in both industrialized and resource-limited settings. Studies employing the IHDS have produced mixed results, with recent data suggesting unusually high rates of dementia among Ugandans. This study aimed to define the performance characteristics of the IHDS in three African countries. Cross-sectional study. We recruited 2208 HIV-infected and 429 HIV-uninfected individuals from East Africa (Kenya n = 1384; Tanzania n = 368; Uganda n = 456) who underwent testing with the IHDS and a 30-minute neuropsychological testing battery. Cognitive impairment was defined as −1SD on two of 6 tests or −2SD on one test compared to demographically matched controls stratified by age and education. We examined predictive capacity of the IHDS to detect cognitive impairment using receiver operator characteristic (ROC) curve analysis. The mean (SD) ages of the HIV-infected and HIV-uninfected groups were 39.7 (10.7) and 37.4 (10.4), respectively. Among HIV-infected individuals, 1508 (68%) were on combination antiretroviral therapy (cART), 1298 (61%) had plasma viral load <500 copies/ml and 884 (38%) met criteria for cognitive impairment. Using the customary IHDS cut-off of 10, 1136 (83%) of the HIV-infected participants met criteria for dementia resulting in 91% sensitivity but only 17% specificity. A modified cut-off score of 8 derived from the ROC resulted in low sensitivity (56%) and specificity (64%). The IHDS has poor performance characteristics for the identification of cognitive impairment in East Africa. Cultural-informed and sensitive screening tests are needed to detect mild cognitive dysfunctions in developing countries.Keywords
This publication has 30 references indexed in Scilit:
- Prevalence and factors associated with probable HIV dementia in an African population: A cross-sectional study of an HIV/AIDS clinic populationBMC Psychiatry, 2013
- A Systematic Review of the Screening Accuracy of the HIV Dementia Scale and International HIV Dementia ScalePLOS ONE, 2013
- Management issues in HIV-associated neurocognitive disordersNeurobehavioral HIV Medicine, 2012
- Lessons Learned Developing a Diagnostic Tool for HIV-Associated Dementia Feasible to Implement in Resource-Limited Settings: Pilot Testing in KenyaPLOS ONE, 2012
- HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictorsJournal of NeuroVirology, 2010
- Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in UgandaBMC Psychiatry, 2010
- Neurocognitive impairment among HIV‐positive individuals in Botswana: a pilot studyJournal of the International AIDS Society, 2010
- Within-Person Across-Neuropsychological Test Variability and Incident DementiaJAMA, 2008
- Clade-Specific Differences between Human Immunodeficiency Virus Type 1 Clades B and C: Diversity and Correlations in C3-V4 Regions of gp120Journal of Virology, 2007
- The CES-D ScaleApplied Psychological Measurement, 1977